<DOC>
	<DOC>NCT02242357</DOC>
	<brief_summary>Study to evaluate efficacy and tolerability of Micardis速/Micardis速 Plus under usual daily-practice prescribing conditions in hypertensive patients</brief_summary>
	<brief_title>Study to Evaluate Efficacy and Tolerability of Micardis速/Micardis速 Plus in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<criteria>Males and females for whom a medical antihypertensive therapy is indicated Age &gt;= 18 years Age &lt; 18 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>